Navigation Links
IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders

HAYWARD, Calif.--(BUSINESS WIRE)--Jun 8, 2007 - IMPAX Laboratories, Inc. (OTC:IPXL) today announced that two poster presentations, highlighting the company's compound, IPX054, a combined immediate- and extended-release carbidopa/levodopa (CD/LD) product to be marketed as VADOVA(TM), were presented at the Movement Disorder Society's 11th International Congress of Parkinson's Disease and Movement Disorders in Istanbul, Turkey on June 7, 2007. The poster presentations will be available in the Investor Relations section of the Company's Web site by clicking on Presentations.

Comparison of Pharmacokinetics and Pharmacodynamics of Combined Immediate- and Extended-Release (IR+ER) Carbidopa/Levodopa Formulations (VADOVA IR+ER) with IR Carbidopa/Levidopa and Controlled-Release Carbidopa/Levodopa in Parkinson's Disease was presented by lead researchers John Nutt, M.D and Peter A. LeWitt, M.D. The study results concluded that at equivalent carbidopa/levodopa dose level (50/200 mg), the combined immediate- and extended release carbidopa/levodopa preparation produces a more rapid onset of clinical response than controlled release carbidopa/levodopa, without the higher peak plasma levodopa concentrations seen with immediate-release carbidopa/levodopa 2x 25/100. The combined immediate- and extended-release preparation may offer benefits in treating Parkinson's Disease (PD) patients with motor fluctuations.

Bi-layer Formulation Of Carbidopa/Levodopa (IPX054) vs. Standard Carbidopa/Levodopa In Stable PD Patients was presented by Christopher G. Goetz M.D. Vanessa K Hinson, M.D. was a co-investigator of the study. The study compared IPX054, a bi-layer tablet of immediate- and extended-release carbidopa/levodopa (CD/LD) given twice daily vs. standard CD/LD given four times daily in patients with stable PD. The study results concluded that in stable PD patients without troublesome dyskinesia, twice daily IPX054 provided comp
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference

Post Your Comments:
(Date:11/25/2009)...ewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUV...g products for minimally disruptive surgical treat...host a conference call on Monday, November 30, 200... call will focus on current issues relative to rei...lude comments from management followed by a short ...
(Date:11/25/2009)... Nov. 25 HeartWare Inter...ng innovator and provider of less invasive, miniat...izing the treatment of advanced heart failure, tod...tor presentation at the 21st Annual Piper Jaffray ..., December 2, 2009. The conference is being held a...
(Date:11/24/2009)...wswire-FirstCall/ -- Quest Diagnostics Incorporate...diagnostic testing, information and services, anno...nual Piper Jaffray Healthcare Conference in New Yo...day, December 2, 2009 at 9:30 a.m. Eastern Time. ,...irm its 2009 guidance for revenue growth to approx...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Hot microbes cause groundwater cleanup rethink 9979 1Hot microbes cause groundwater cleanup rethink 9979 2Researchers prolong the half life of biopharmaceutical proteins 9974 1Researchers prolong the half life of biopharmaceutical proteins 9974 2Quantros and HealthWatch Announce PSO Partnership 57645 1Quantros and HealthWatch Announce PSO Partnership 57645 2Quantros and HealthWatch Announce PSO Partnership 57645 3
...ertension medications largest among ...f women using heart disease medications greater th...ase,high blood pressure and hardening of the arter...the senior population - are creeping into young,ad...dco Health Solutions,Inc. (NYSE: MHS ), prescript...
...,(Nasdaq: NVAX ) Chief Executive Officer Dr. Rahu...l Healthcare Conference at 10:55 am Eastern time o...l, New York City, the,company announced today. Dr...s strategy,research and development progress and s...of his presentation will be available at 10:55 am ...
Other Medicine Technology:Younger Adults Increasingly Treated for Heart Disease-related Conditions 2Younger Adults Increasingly Treated for Heart Disease-related Conditions 3Younger Adults Increasingly Treated for Heart Disease-related Conditions 4Novavax CEO to Present at ACUMENBioFin's 9th Annual Healthcare Conference 2
(Date:11/27/2009)... Biotech firm Replikins Ltd. toda...N1 virus genomic data. It shows that the lethalit....d. 4.5) during the virus,s current outbreak in th...is week of 2.0 (s.d. 0.1). The H1N1 infectivity co... Boston (PRWEB) November 27, 2009 -- Biot...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewswi...professional cycling team dedicated to ethical spo...g champions, announced today that it will become T...tions Optical as a new sponsor of the team. Transi...of adaptive eyewear, offering the most advanced ph...
(Date:11/27/2009)...rates to bring unprecedented medical, economic bur... (HealthDay News) -- The number of people with dia...ver the next 25 years, a new study predicts. , ...illion people with the disease, up from 23.7 milli...ting people with diabetes will triple, the study a...
(Date:11/27/2009)... Specialist manufacturers who use... are saving millions of dollars by bringing in tec...s. Increasing numbers of pro-active medical manufa...t the concept stage of their projects, ensuring th...sign processes or potentially outdated technology....
(Date:11/26/2009)... next 25 years, the number of Americans living wit...7 million in 2009 to 44.1 million in 2034. Over th...iple, rising from $113 billion to $336 billion, ev...researchers based at the University of Chicago rep...The number of those with diabetes covered by Medic...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...ol tablet Paratabs 500mg are being recalled by the...on which is most likely to be mould//. This applie...s people could not have purchased the product with...o quarantine their unsold stocks. Last month,...
...f adults with autism has provided new evidence tha...mental disorder may not communicate// with each ot... Researchers from the University of Washington’s ...igh-resolution electroencephalography (EEG) to exa...
...y of South Florida and the James A. Haley Veterans...essing Post-Traumatic Stress Disorder// (PTSD). Th...ical stress produces behavioral symptoms in animal...of stress, in conjunction with daily social stress...
...iscovery that a gene called IRF6 is involved in th...chers at the University of Iowa Roy J. and// Lucil...ues have identified the function of the gene. Thei...overy that may have implications for wound healing...
...inked to several harms such as the increased likel...erapy according to research published// today. ...t screening programs were studied by researchers a... invited to have mammograms over a 10-year period,...
...ic have conducted a randomised, placebo controlled...dy the effects of the popular antiaging// suppleme...hed in the New England Journal of Medicine (Oct 19...e any marked impact on the popular measures of age...
Other Medicine News:Health News:Brain Regions Do Not Communicate Efficiently in Adults with Autism 2Health News:Stress Produces PTSD-like Symptoms in Rats 2Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 2Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 3Health News:Breast cancer screening :Benefits vs Harm 2Health News:The Search For Eternal Youth-DHEA Not The Magic Potion 2
XR Cubital Tunnel Elbow Splint
EpiPoint
...buckle Elbow Orthosis applies dynamic low-loaded f...ols elbow contracture in patients with paralysis o...ood for elbow flexion and extension contracture po...ly tension (but not torque) to the elbow. This pos...
...r Walking Brace is designed to add the therapeutic...lker™ (sold separately). When inserted into ...e cuff surrounds the foot and ankle with soothing ...lling, and pain.,All Cryo/Cuffs can be ordered as...
Medicine Products: